Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 20 July

Paulina Peters
July 20, 2021

Morning Bell 19 July

Jessica Amir
July 19, 2021

Weekly Wrap 16 July

Jessica Amir
July 16, 2021

Morning Bell 16 July

Sophia Mavridis
July 16, 2021

Morning Bell 15 July

Paulina Peters
July 15, 2021

Morning Bell 14 July

Jessica Amir
July 14, 2021

Morning Bell 13 July

Jessica Amir
July 13, 2021

Morning Bell 12 July

Jessica Amir
July 12, 2021

Weekly Wrap 9 July

Jessica Amir
July 9, 2021

Morning Bell 9 July

Paulina Peters
July 9, 2021

Morning Bell 8 July

Jessica Amir
July 8, 2021